Saka B, Dzidzinyo K, Akakpo S, Téclessou J, Nouhou Diori A, Maneh N, Mahamadou G, Gnassingbé W, Abilogun-Chokki A, Mouhari-Toure A, Boubacar Y Ali, Kombaté K, Balo K, Tchangai-Walla K, Pitché P
Service de dermatologie et IST, CHU de Sylvanus Olympio, université de Lomé, BP 30785, Lomé, Togo.
Service d'ophtalmologie, CHU de Sylvanus Olympio, université de Lomé, Lomé, Togo.
Ann Dermatol Venereol. 2018 Apr;145(4):245-249. doi: 10.1016/j.annder.2018.01.040. Epub 2018 Feb 24.
The purpose of this study was to identify risk factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) in sub-Saharan Africa.
A retrospective study was carried out at the dermatology department in collaboration with the ophthalmology department for SJS/TEN patients between January 2000 and December 2016 in Lomé (Togo). The severity of acute ocular involvement was evaluated using the Power classification, and the drug eruption score was assessed using de Bastuji-Garin classification.
A total of 107 cases of SJS/TEN (84 cases of SJS, 20 cases of TEN and 3 cases of overlap syndrome) were analyzed. There were 71 women and 36 men, with an average age of 32.3±12.5 years (range: 5 to 75 years). Sulfonamides (37.4%) were the most commonly used drugs followed by nevirapine (22.4%). HIV serology was positive in 46 (58.2%) of the 79 patients tested. A total of 54 (50.5%) patients had acute ocular involvement, which was mild in 29.9% of patients, moderate in 13.1% and severe in 7.5%. In multivariate analysis, exposure to sulfadoxine was the sole factor associated with moderate or severe acute ocular involvement in SJS/TEN (adjusted odds ratio=3.3; 95% CI=[1.1; 10.2]).
Exposure to sulfadoxine was identified in our study as a risk factor associated with the severity of acute ocular involvement in SJS/TEN. Multicenter studies should be conducted in sub-Saharan Africa to confirm this associated risk factor.
本研究旨在确定撒哈拉以南非洲地区史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症(SJS/TEN)急性眼部受累严重程度的相关危险因素。
2000年1月至2016年12月期间,在洛美(多哥)的皮肤科与眼科合作,对SJS/TEN患者进行了一项回顾性研究。采用Power分类法评估急性眼部受累的严重程度,使用德巴斯蒂吉-加兰分类法评估药疹评分。
共分析了107例SJS/TEN病例(84例SJS、20例TEN和3例重叠综合征)。其中女性71例,男性36例,平均年龄32.3±12.5岁(范围:5至75岁)。磺胺类药物(37.4%)是最常用的药物,其次是奈韦拉平(22.4%)。79例接受检测的患者中,46例(58.2%)HIV血清学呈阳性。共有54例(50.5%)患者出现急性眼部受累,其中29.9%的患者为轻度,13.1%为中度,7.5%为重度。多因素分析显示,暴露于周效磺胺是SJS/TEN患者中度或重度急性眼部受累的唯一相关因素(调整比值比=3.3;95%置信区间=[1.1;10.2])。
在我们的研究中,暴露于周效磺胺被确定为与SJS/TEN急性眼部受累严重程度相关的危险因素。应在撒哈拉以南非洲地区开展多中心研究以证实这一相关危险因素。